Cargando…

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease

BACKGROUND: Neurodegenerative disorders such Alzheimer's disease (AD) are often characterized by senile plaques and neurofibrillary tangle. In addition, reactive astrogliosis, microglia activation and a chronic inflammation are found in AD brain. Activated microglia has been reported to express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porcellini, Elisa, Ianni, Manuela, Carbone, Ilaria, Franceschi, Massimo, Licastro, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610278/ https://www.ncbi.nlm.nih.gov/pubmed/23432970 http://dx.doi.org/10.1186/1742-4933-10-6

Ejemplares similares

Alzheimer's disease gene signature says: beware of brain viral infections
por: Porcellini, Elisa, et al.
Publicado: (2010)

Altered glycosylation profile of purified plasma ACT from Alzheimer’s disease
por: Ianni, Manuela, et al.
Publicado: (2010)

The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer’s Disease
por: Licastro, Federico, et al.
Publicado: (2014)

Variations in inflammatory genes are associated with periodontitis
por: Ianni, Manuela, et al.
Publicado: (2013)

Impaired Innate Immunity Mechanisms in the Brain of Alzheimer’s Disease
por: Romagnoli, Martina, et al.
Publicado: (2020)

Multi factorial interactions in the pathogenesis pathway of Alzheimer’s disease: a new risk charts for prevention of dementia
por: Licastro, Federico, et al.
Publicado: (2010)

Persistent infections, immune-senescence and Alzheimer's disease
por: Licastro, Federico, et al.
Publicado: (2016)

Activation of Endogenous Retrovirus, Brain Infections and Environmental Insults in Neurodegeneration and Alzheimer’s Disease
por: Licastro, Federico, et al.
Publicado: (2021)

Analysis of the Monocyte Chemoattractant Protein 1 -2518 Promoter Polymorphism in Korean Patients with Alopecia Areata
por: Hong, Seok-Beom, et al.
Publicado: (2006)

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Yong, Kok-Khun, et al.
Publicado: (2016)

A functional promoter polymorphism in monocyte chemoattractant protein–1 is associated with increased susceptibility to pulmonary tuberculosis
por: Flores-Villanueva, Pedro O., et al.
Publicado: (2005)

Pro-inflammatory genetic profile and familiarity of acute myocardial infarction
por: Ianni, Manuela, et al.
Publicado: (2012)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Serum neutrophil gelatinase-B associated lipocalin (NGAL) levels in Down’s syndrome patients
por: Dogliotti, Giada, et al.
Publicado: (2010)

Association of Polymorphisms in Monocyte Chemoattractant Protein-1 Promoter with Diabetic Kidney Failure in Korean Patients with Type 2 Diabetes Mellitus
por: Moon, Ju-young, et al.
Publicado: (2007)

Innate immunity and inflammation in ageing: a key for understanding age-related diseases
por: Licastro, Federico, et al.
Publicado: (2005)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain Injury
por: Licastro, Federico, et al.
Publicado: (2016)

The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
por: Yoshimura, Teizo, et al.
Publicado: (2023)

Data on early postoperative changes in aqueous monocyte chemoattractant protein-1 levels after phacoemulsification
por: Kawai, Motofumi, et al.
Publicado: (2016)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
por: Lee, Seong-Kyu
Publicado: (2017)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Relationship between dietary folate intake and plasma monocyte chemoattractant protein-1 and interleukin-8 in heart failure patients
por: Chung, Hye Kyung, et al.
Publicado: (2011)

Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: A prospective observational study
por: Wang, Yuchang, et al.
Publicado: (2018)

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
por: Graupera, Isabel, et al.
Publicado: (2016)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
por: Martín-Reyes, Roberto, et al.
Publicado: (2016)

Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans
por: Yousefzadeh, Matthew J., et al.
Publicado: (2017)

High-fat diet increases the level of circulating Monocyte Chemoattractant Protein-1 in Wistar rats, independent of obesity
por: Syarif, et al.
Publicado: (2021)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p1mf716nlbv1h7m1om8nlkuoih